EDC vs. Paper :: True Costs and Options
Presented by
Ed Slezinger :: Industry Consultant
Neil Warnock, MD, MBA :: VP of Medical Affairs, StudyManager
Emerging and established companies alike face the difficult “EDC vs. Paper” question when considering data management for an upcoming trial. Often, paper is reluctantly chosen due to the perceived prohibitive costs of EDC. Many of the current EDC systems offer modular tools and varying degrees of system integration, applicable to stakeholders large and small.
This webinar examines the true costs of EDC vs. paper solutions, with a comprehensive consideration of all resources involved. The results of a recent survey of data managers on the challenges of EDC implementation will be discussed, and a case will be presented that shows EDC can be a cost-effective option, even for early phase or smaller trials.
Presented By
Ed Slezinger - Industry Consultant
Neil
Warnock, MD, MBA - VP of Medical Affairs, StudyManager
About the Presenters
Ed Slezinger is a clinical development executive with more than 14 years of hands-on and leadership experience in Pharmaceutical, Biotech, CRO and EDC software development. His experience and industry service has been with large and small pharma (Pfizer, Cell Therapeutics), large and small device (St. Jude Medical, 3F Therapeutics), Global CRO (PRA International) and EDC software development (Medidata) in preclinical and clinical development programs in Data Management, Project Analysis and EDC.
Dr. Neil Warnock is Vice President of Medical Affairs for StudyManager. Dr. Warnock possesses broad experience in medicine from clinician to Medical Liaison, to Medical Director. He has worked in clinical development, health economics and managed care. Dr. Warnock has worked in all phases of clinical research across several therapeutic areas and many different job responsibilities including clinical trial design, physician education, patient retention, and others.
Please register below to view this webinar:
| State/Province:* |
|
|
| Country:* |
|
|
| Industry:* |
|
|